Orchid Chemicals & Pharmaceuticals receives approval for ANDA for Gemifloxacin Mesylate Tablets
From USFDA
Orchid Chemicals & Pharmaceuticals announced that the Company has received approval from the US FDA for the Abbreviated New Drug Application (ANDA) for Gemifloxacin Mesylate Tablets (320 mg) with 180 days of generic drug exclusivity.Powered by Capital Market - Live News